Drug recall · December 12, 2012
Levothroid recall
Why: cGMP Deviations; does not meet in process specification requirements
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.
- Lots / codes
Lot #1095210, exp. 4/30/2013
- Quantity
- 19,162/100-tablet bottles
- Company
- Lloyd Inc. of Iowa, Shenandoah, IA
- Distribution
- Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
- Initiated
- July 9, 2012 · Voluntary: Firm initiated
- Classified
- December 3, 2012
- Reported
- December 12, 2012
- Ended
- November 14, 2013
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.